Plasma Viruses Meet Another Foe
PCR Screening Continues at Aventis Behring
KING OF PRUSSIA, PA-Aventis Behring recently presented information to the Food and Drug Administration (FDA) about its ongoing investigation regarding the use of proprietary polymerase chain reaction (PCR) technology to screen for the presence of certain viruses in plasma. PCR screening, a form of nucleic acid testing (NAT), can detect very low levels of a material and, therefore, may enable the detection of viruses at an earlier stage than traditional screening methods such as serology tests. Aventis Behring's data indicates PCR screening may be effective in identifying the hepatitis B virus in plasma that has passed undetected in previous serology tests that screen for hepatitis B surface antigen. In an analysis of 3,250,000 plasma samples that received negative results for hepatitis B surface antigen, researchers used their PCR technology and found that 62 samples from 42 donors contained the virus.
Many manufacturers of plasma products are using NAT as a part of their screening process. Though still investigational, the process is considered another step in an ongoing safety conscious field. Aventis Behring is committed to PCR screening and only manufactures products from plasma that has been screened for HIV-1; hepatitis A, B, and C; and parvovirus B19.
Canada Faces Rising Measles Cases: Public Health Urges Vaccination Amid Growing Threat
March 6th 2025Measles cases in Canada are rising, with 227 infections reported in early 2025. Public health officials urge vaccination to prevent outbreaks, severe complications, and further community transmission.
Surging Whooping Cough Cases Highlight the Importance of Vaccination
March 6th 2025Experts like Michael Glazier, MD, warn that waning immunity, declining vaccination rates, and increased transmission are driving this resurgence. Vaccination remains the best defense, with pediatricians urging timely immunization to protect vulnerable populations and prevent further outbreaks.
Measles Outbreak Sparks APIC’s Urgent Call for Stronger Vaccine Policies
March 4th 2025The recent measles-related death in Texas has reignited fears about the consequences of declining vaccination rates and misinformation. Once declared eliminated in the US, measles is resurging with over 150 cases and climbing. APIC warns: this crisis is preventable—but only if we act now.
